This brand name is authorized in Germany, Malta
The drug ALFASON contains one active pharmaceutical ingredient (API):
|
1
Hydrocortisone butyrate
UNII 05RMF7YPWN - HYDROCORTISONE BUTYRATE
|
|
Hydrocortisone butyrate is the butyrate salt form of hydrocortisone, a synthetic glucocorticoid receptor agonist with antiinflammatory, antipruritic and vasoconstrictive effects. Binding and activation of the glucocorticoid receptor results in the activation of lipocortin that in turn inhibits cytosolic phospholipase A2. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| D07AB02 | Hydrocortisone butyrate | D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07A Corticosteroids, plain → D07AB Corticosteroids, moderately potent (group II) |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: DE | Bundesinstitut fĂźr Arzneimittel und Medizinprodukte | Identifier(s): 01995025, 01995054, 01995083, 02094761, 02094778, 02387486, 02387492, 03235821, 04613509, 04782347, 04782353, 04829787 |
| Country: MT | Medicines Authority | Identifier(s): AA565/80201 |
Š All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
